Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Pyxis Oncology, Inc. (PYXS) had Operating Cash Flow per Share of $-1.02 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$11.04M |
|
$-18.11M |
|
-- |
|
$11.04M |
|
$29.33M |
|
$-18.30M |
|
$1.29M |
|
$-17.00M |
|
$-17.00M |
|
$-18.11M |
|
$-18.11M |
|
$-18.11M |
|
$-18.11M |
|
$-18.30M |
|
$-15.77M |
|
62.14M |
|
62.14M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$72.11M |
|
$8.00M |
|
$19.41M |
|
$91.52M |
|
$21.13M |
|
-- |
|
$16.98M |
|
$38.11M |
|
$53.41M |
|
$53.41M |
|
$53.41M |
|
62.69M |
|
| Cash Flow Statement Financials | |
$-63.50M |
|
$58.86M |
|
$0.59M |
|
$20.95M |
|
$16.89M |
|
$-4.05M |
|
$11.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
78.37% |
|
-165.75% |
|
-165.75% |
|
-- |
|
-154.04% |
|
-164.03% |
|
$-63.51M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
-33.90% |
|
-33.90% |
|
-19.78% |
|
-33.90% |
|
$0.85 |
|
$-1.02 |
|
|
Operating Cash Flow per Share |
$-1.02 |